Patients at risk of onychomycosis -: risk factor identification and active prevention

被引:77
作者
Tosti, A
Hay, R
Arenas-Guzmán, R
机构
[1] Univ Bologna, I-40124 Bologna, Italy
[2] Queens Univ Belfast, Fac Med & Hlth Sci, Belfast BT9 7BL, Antrim, North Ireland
关键词
onychomycosis; prevention; recurrence; risk factors;
D O I
10.1111/j.1468-3083.2005.01282.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objectives The aims of this workshop were to identify risk factors for onychomycosis and to reach consensus on the management of high-risk groups to allow the development of guidelines to help doctors recognize risk factors that complicate treatment. Results and Conclusions Previous Trichophyton rubrum infection, older age, abnormal nail morphology, immunodeficiency and genetic factors were identified as risk factors for initial infections. Risk factors for recurrence (relapse and re-infection) are largely the same. The experts agreed that the prevention of onychomycosis and its recurrence should be based on the correct treatment of tinea pedis, screening family members and adequate patient education. In addition, generic management recommendations for each high-risk group were discussed: Immunosuppressed patients Usual dose and treatment length not appropriate Follow-up required Beware of drug interactions Diabetics Prophylactic foot care combined with nail treatment Good opportunity for patient education, footwear, foot care, etc. Beware of drug interactions Psoriatics and patients with abnormal nails Dermatophyte eradication does not restore normal nails Children High failure rate possibly due to compliance problems.
引用
收藏
页码:13 / 16
页数:4
相关论文
共 21 条
[1]   Prevalence of superficial fungal infections among sports-active individuals: results from the Achilles survey, a review of the literature [J].
Caputo, R ;
De Boulle, K ;
Del Rosso, J ;
Nowicki, R .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2001, 15 (04) :312-316
[2]   Nail changes in patients infected with human immunodeficiency virus -: A prospective controlled study [J].
Cribier, B ;
Mena, ML ;
Rey, D ;
Partisani, M ;
Fabien, V ;
Lang, JM ;
Grosshans, E .
ARCHIVES OF DERMATOLOGY, 1998, 134 (10) :1216-1220
[3]  
de Ocariz MDS, 2001, INT J DERMATOL, V40, P18, DOI 10.1046/j.1365-4362.2001.00181.x
[4]   Epidemiology of onychomycosis in patients with diabetes mellitus in India [J].
Dogra, S ;
Kumar, B ;
Bhansali, A ;
Chakrabarty, A .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2002, 41 (10) :647-651
[5]   Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions [J].
Elewski, BE ;
Charif, MA .
ARCHIVES OF DERMATOLOGY, 1997, 133 (09) :1172-1173
[6]   Genetic predisposition - understanding underlying mechanisms of onychomycosis [J].
Faergemann, J ;
Correia, O ;
Nowicki, R ;
Ro, BI .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2005, 19 :17-19
[7]   Epidemiology, clinical presentation and diagnosis of onychomycosis [J].
Faergemann, J ;
Baran, R .
BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 :1-4
[8]  
Gianni C, 1999, EUR J DERMATOL, V9, P390
[9]  
Gudnadóttir G, 1999, ACTA DERM-VENEREOL, V79, P376, DOI 10.1080/000155599750010319
[10]  
Gupta AK, 1998, BRIT J DERMATOL, V139, P665, DOI 10.1046/j.1365-2133.1998.02464.x